查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018632

眼科縫合線市場：2026-2032年全球市場預測（按產品類型、材料、縫線類型、應用和最終用戶分類）

Ophthalmic Sutures Market by Product Type, Material, Suture Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，眼科縫線市場價值將達到 4.5902 億美元，到 2026 年將成長至 4.9573 億美元，到 2032 年將達到 7.8093 億美元，複合年成長率為 7.88%。

主要市場統計數據
基準年 2025 4.5902億美元
預計年份：2026年 4.9573億美元
預測年份 2032 7.8093億美元
複合年成長率 (%) 7.88%

簡潔地介紹了影響現代眼科縫合線選擇的臨床重點、技術差異和購買決策因素，無論手術環境如何。

眼科縫合線仍然是眼前節和後節手術中不可或缺的一部分，材料科學、操作性能和監管途徑的細微差異都會影響臨床選擇。過去十年，外科醫生和採購團隊越來越重視諸如減少組織反應、可預測的結紮強度以及顯微鏡下易於操作等結果。這些優先事項推動了可吸收和不可吸收縫合線的多樣化，促使供應商改進聚合物配方和絲材結構，以滿足顯微外科手術的需求。

聚合物創新、顯微外科技術的進步以及採購系統的整合如何從根本上改變眼科縫合線的臨床應用和供應商策略。

近年來，眼科縫合線領域發生了一系列變革性變化，正在重塑製造商、臨床醫生和供應鏈相關人員對眼科縫合線的認知和應用方式。聚合物化學和絲材工程的進步改進了可吸收產品，例如氧環己酮聚合體和Polyglactin910，同時也提高了不可吸收纖維（例如聚醯胺和聚酯）的表面光潔度和抗張強度可靠性。這些材料層面的創新降低了組織阻力，提高了結紮強度，從而直接轉化為更高的術中效率和更好的術後癒合效果。

評估 2025 年美國關稅調整對眼科縫合線籌資策略、供應鏈韌性和合約條件的影響。

2025年美國政策的轉變和關稅調整為包括眼科縫線在內的外科耗材的採購籌資策略帶來了新的變數。隨著部分醫療設備進口關稅的提高，醫療產業的買家和分銷商正在重新評估供應商所在地，並探索近岸外包和區域採購模式，以降低關稅和前置作業時間風險。為此，一些製造商正在加快對本地生產的投資，或簽訂雙重採購協議，以確保向醫院、門診手術中心和眼科診所的供應持續性。

基於細分的詳細洞察，將聚合物化學、絲狀結構、外科應用和最終用戶採購行為與產品策略聯繫起來。

了解產品和應用細分有助於發現臨床需求與供應商能力最能有效結合的領域。依產品類型分為可吸收和不可吸收兩類時，當減少組織吸收和長期異物滯留是臨床優先事項時，可吸收材料（例如氧環己酮聚合體、Polyglactin910和聚乙醇酸）往往是首選。另一方面，不可吸收纖維（例如聚醯胺、聚酯和絲）在需要持久拉伸強度的適應症中仍扮演重要角色。從材料角度來看，選擇聚醯胺、氧環己酮聚合體、聚酯、Polyglactin910、聚乙醇酸和絲等特定聚合物涉及不同的操作特性和生物相容性考量，這些因素會影響外科醫生的選擇和標籤要求。

美洲、歐洲、中東和非洲以及亞太地區的區域臨床實踐、法規環境和供應鏈特徵如何決定差異化的市場進入策略。

區域趨勢對眼科縫合線的法規結構、報銷機制和供應鏈設計有顯著影響。在美洲，成熟的臨床路徑和龐大的手術量使得對產品一致性、外科醫生培訓支援和檢驗的產品性能有強烈的需求。另一方面，採購團隊更傾向於選擇能夠展現完善的品質系統和快速交貨能力的供應商。在歐洲、中東和非洲，監管環境的差異以及公立和私立醫療體系的不同，使得企業需要靈活的打入市場策略、本地化的臨床證據以及能夠適應不同報銷方案和醫院採購模式的有針對性的分銷商合作夥伴關係。

決定一家公司在眼科縫合線領域競爭優勢的關鍵優勢、經銷夥伴和品質保證措施。

眼科縫合線市場的競爭格局由那些將先進材料技術、與臨床醫生緊密合作以及可靠的供應鏈相結合的公司所主導。主要企業投資於聚合物研發、絲材表面工程和客觀的可用性測試，以改善產品特性，例如結紮強度、組織耐受性和顯微操作性。同樣重要的是，企業還需具備透過合作研究支持臨床檢驗的能力，以及提供培訓以加速外科醫生採用新產品的能力，因為外科醫生在選擇產品時通常依賴觸覺回饋。

為製造商和經銷商制定可操作的優先行動方案，使創新、檢驗和供應彈性與臨床和採購優先事項保持一致。

產業領導企業應採取協作策略，將產品創新、臨床檢驗和供應鏈韌性相結合，以最大限度地滿足不斷變化的外科手術需求和採購預期。首先，研發專案應優先解決明確的臨床挑戰，例如降低組織阻力、提高超細線結的強度以及確保不同批次產品操作性能的一致性，並透過外科醫生主導的可用性研究和有記錄的台架測試來檢驗這些進展。其次，透過採購多元化、建立替代供應商和近岸生產，可以降低關稅和海關程序差異帶來的風險，同時即使材料被替代，也能維持等效性檢驗方案。

對眼科縫合線的策略分析，提供一級和二級調查方法、數據三角測量和局限性的透明解釋。

本研究結合了對眼科醫生、採購經理和行業專家的訪談，以及對監管指南、材料科學文獻和公開臨床研究的二次分析，這些研究均與眼科縫合線的性能相關。主要數據包括對不同專科的眼科醫生、門診手術中心和醫院的採購負責人以及檢驗進貨批次的滅菌和品質保證專家的結構化訪談和定性可用性測試。次要資訊包括關於聚合物生物相容性、結節動態和縫合線處理的同行評審研究，以及概述主要司法管轄區無菌醫療設備要求的監管文件。

臨床、商業性和供應鏈要求概述，決策者應將其納入考量，以確保績效的一致性和採購的韌性。

眼科縫線處於材料科學、顯微外科技術和醫療採購等關鍵領域的交匯點，因此需要一種將臨床證據與供應可靠性相結合的精細化方法。最有效的策略強調可驗證的產品性能，並透過外科醫生主導的可用性測試和客觀的基準測試檢驗，同時結合滅菌、文件記錄和物流方面的卓越運作。近期區域和政策的發展，包括關稅調整，凸顯了多元化採購和合約保障措施的必要性，以確保向醫院、門診手術中心和眼科診所的持續供應。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：眼科縫合線市場：依產品類型分類

  • 吸收性
    • 氧環己酮聚合體
    • Polyglactin910
    • 聚乙醇酸
  • 不吸收
    • 聚醯胺
    • 聚酯纖維
    • 絲綢

第9章：眼科縫合線市場：依材料分類

  • 聚醯胺
  • 氧環己酮聚合體
  • 聚酯纖維
  • Polyglactin910
  • 聚乙醇酸
  • 絲綢

第10章：眼科縫合線市場－依縫合線類型分類

  • 編織
  • 單絲

第11章：眼科縫合線市場：按應用領域分類

  • 白內障
  • 角膜
  • 青光眼
  • 鏡頭維修

第12章：眼科縫合線市場：依最終用戶分類

  • 門診手術中心
  • 眼科診所
  • 醫院

第13章：眼科縫合線市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 眼科縫合線市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 眼科縫合線市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國眼科縫合線市場

第17章：中國眼科縫合線市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alcon Inc.
  • Aurolab
  • B. Braun Melsungen AG
  • Demetech Corporation
  • Ethicon, Inc.
  • Johnson & Johnson Vision
  • Lotus Surgicals Pvt. Ltd.
  • Mani, Inc.
  • Medical Micro Instruments, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Peters Surgical Limited
  • Serag-Wiessner GmbH & Co. KG
  • Surgical Specialties Corporation
  • SUTUREMED Co., Ltd.
  • Teleflex Incorporated
Product Code: MRR-221461476CEA

The Ophthalmic Sutures Market was valued at USD 459.02 million in 2025 and is projected to grow to USD 495.73 million in 2026, with a CAGR of 7.88%, reaching USD 780.93 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 459.02 million
Estimated Year [2026] USD 495.73 million
Forecast Year [2032] USD 780.93 million
CAGR (%) 7.88%

Concise introduction to the clinical priorities, technical differentiators, and purchasing drivers shaping modern ophthalmic suture selection across surgical settings

Ophthalmic sutures remain a foundational component of anterior and posterior segment surgery, with nuanced differences in material science, handling characteristics, and regulatory pathways driving clinical choice. Over the past decade, surgeons and procurement teams have increasingly prioritized outcomes such as reduced tissue reaction, predictable knot security, and ease of handling under microscopic visualization. These priorities have fueled diversification in both absorbable and nonabsorbable options and prompted suppliers to refine polymer formulation and filament architecture to meet microsurgical demands.

Clinical practice has migrated toward specialized suture sizes and formats to support delicate ocular tissues; ultrafine gauges from 10-0 through 9-0 accommodate precise corneal and lens repair while slightly larger sizes serve broader reconstructive needs. At the same time, suture type distinctions-braided versus monofilament-affect tissue drag, knot profile, and infection risk, influencing surgeon selection depending on the procedure. In parallel, end user environments including ambulatory surgery centers, dedicated eye clinics, and hospital ophthalmology departments are shaping purchasing criteria through case mix, throughput needs, and sterile processing capabilities.

Taken together, these dynamics set the stage for strategic investment in product training, supply reliability, and targeted material innovation that aligns with surgeon technique and institutional requirements.

How polymer innovation, microsurgical technique evolution, and procurement consolidation are fundamentally reshaping clinical use and supplier strategies for ophthalmic sutures

Recent years have delivered several transformative shifts that recalibrate how manufacturers, clinicians, and supply chain stakeholders approach ophthalmic sutures. Advances in polymer chemistry and filament engineering have refined absorbable offerings such as polydioxanone and polyglactin 910 while also improving the surface finish and tensile reliability of nonabsorbable fibers like polyamide and polyester. These material-level innovations have reduced tissue drag and enhanced knot security, translating directly into intraoperative efficiency and postoperative healing trajectories.

Concurrently, clinical technique evolution and heightened emphasis on minimally invasive approaches have amplified demand for ultrafine suture sizes and monofilament options that permit atraumatic passage through delicate ocular tissue. Training and surgeon preference trends underscore the importance of handling characteristics; as a result, manufacturers are investing in tactile testing and surgeon-led usability studies to differentiate product lines. Another notable shift is the consolidation of procurement pathways and a push for just-in-time stocking in ambulatory surgery centers, eye clinics, and hospital departments, which elevates the importance of consistent supply and validated sterilization practices.

Together, these shifts require stakeholders to balance innovation with rigorous clinical validation and reliable logistics, creating opportunities for companies that can demonstrate both material performance and supply resilience.

Assessing the implications of United States tariff adjustments in 2025 on sourcing strategies, supply chain resilience, and contractual terms for ophthalmic suture supply

Policy shifts and tariff adjustments in the United States in 2025 have introduced new variables into procurement and sourcing strategies for surgical consumables, including ophthalmic sutures. Heightened import levies on certain medical device categories have prompted healthcare buyers and distributors to re-evaluate supplier footprints and to explore nearshoring or regional sourcing models that can mitigate customs exposure and lead-time risk. In response, some manufacturers have accelerated local manufacturing investments or established dual-sourcing agreements to preserve continuity for hospitals, ambulatory surgery centers, and eye clinics.

These changes have also influenced commercial contracting mechanics. Buyers increasingly seek longer-term agreements with price-variance clauses tied to trade policy changes and insist on greater transparency around country-of-origin labeling and tariff pass-through. For product development teams, regulatory and customs complexity has reinforced the value of harmonized quality systems and well-documented compliance evidence that supports alternate sourcing where necessary. From a clinical perspective, practitioners remain focused on consistency of product performance; therefore, any changes in supply chain or material sourcing must be validated through bench testing and clinical equivalency protocols prior to large-scale adoption.

Overall, the 2025 tariff environment has accelerated supply chain diversification, emphasized the importance of sourcing transparency, and reshaped negotiations between suppliers and end users to ensure uninterrupted delivery of clinically critical ophthalmic suture products.

Detailed segmentation-driven insights connecting polymer chemistry, filament architecture, surgical application, and end user procurement behaviors to product strategy

Understanding product and application segmentation illuminates where clinical needs and supplier capabilities intersect most meaningfully. When products are categorized by Product Type into absorbable and nonabsorbable classes, absorbable options such as polydioxanone, polyglactin 910, and polyglycolic acid are often preferred when tissue absorption and reduced long-term foreign body presence are clinical priorities, whereas nonabsorbable fibers such as polyamide, polyester, and silk remain relevant for indications requiring durable tensile support. Looking at Material, discrete polymer choices including polyamide, polydioxanone, polyester, polyglactin 910, polyglycolic acid, and silk infer distinct handling profiles and biocompatibility considerations that guide surgeon selection and labeling requirements.

Suture Type segmentation into braided versus monofilament formats highlights trade-offs between knot security and tissue drag, which are particularly relevant for ultrafine suture sizes like 10-0, 9-0, 8-0, 7-0, and 6-0 used in anterior segment procedures. Application segmentation covering cataract, cornea, glaucoma, and lens repair clarifies clinical procedural demands and informs portfolio prioritization; for example, cataract and corneal surgeries often require the finest diameters and lowest tissue drag, while glaucoma procedures may emphasize longer-term tensile stability. End User segmentation across ambulatory surgery centers, eye clinics, and hospitals underscores differences in procurement cycles, inventory volume, and sterilization resources, each of which shapes product selection, packaging format, and service expectations from suppliers.

Integrating these segmentation lenses provides a granular framework for aligning R&D investments, clinical validation programs, and commercial strategies to specific surgical workflows and purchasing behaviors.

How regional clinical practices, regulatory environments, and supply chain characteristics across the Americas, Europe Middle East & Africa, and Asia-Pacific dictate differentiated go-to-market approaches

Regional dynamics exert substantial influence on regulatory frameworks, reimbursement practices, and supply chain design for ophthalmic sutures. In the Americas, well-established clinical pathways and high procedural volumes drive strong demand for consistency, surgeon training support, and validated product performance, while procurement teams favor suppliers that can demonstrate robust quality systems and rapid fulfillment. Across Europe, Middle East & Africa, regulatory heterogeneity and differing public versus private healthcare mixes create a need for flexible market entry strategies, localized clinical evidence, and targeted distributor partnerships that can navigate varied reimbursement and hospital purchasing models.

In the Asia-Pacific region, rapid adoption of advanced surgical techniques coexists with a wide spectrum of healthcare infrastructure, prompting suppliers to offer both premium performance lines and cost-competitive formats to meet diverse needs. Supply chain considerations such as lead time, local manufacturing presence, and responsiveness to clinical education requests vary significantly across these geographies, and stakeholders should tailor their market access approach accordingly. Transitioning from one region to another requires adaptation not only in regulatory dossiers and labeling but also in training, packaging sizes, and service models to align with local institutional workflows and surgeon expectations.

Consequently, effective regional strategies balance centralized product excellence with decentralized execution that acknowledges the clinical and commercial realities of each territory.

Key corporate competencies, distribution partnerships, and quality assurance practices that define competitive advantage in the ophthalmic suture sector

The competitive landscape for ophthalmic sutures is shaped by companies that combine advanced materials expertise with strong clinician engagement and supply chain reliability. Leading manufacturers invest in polymer development, filament surface engineering, and unbiased usability testing to refine product attributes such as knot security, tissue drag, and handling under microscopy. Equally important is the capability to support clinical validation through collaborative studies and to provide training that accelerates adoption among surgeons who often rely on tactile feedback for product selection.

Distribution partners and contract manufacturers also play a strategic role by offering scale, local market access, and sterile processing competencies. Companies that demonstrate transparent quality systems, consistent lot-to-lot performance, and robust regulatory documentation gain an advantage when hospitals and ambulatory centers evaluate supplier risk. Moreover, organizations that proactively address sustainability in packaging and manufacturing processes, while not compromising sterile integrity, are increasingly preferred by procurement teams focused on long-term operational resilience.

In sum, success in this space requires a balanced portfolio of material innovation, clinician-centered evidence generation, and an agile supply model that anticipates regional compliance and logistical requirements.

Practical and prioritized actions for manufacturers and distributors to align innovation, validation, and supply resilience with clinical and procurement priorities

Industry leaders should adopt a coordinated strategy that aligns product innovation, clinical validation, and supply chain resilience to capitalize on evolving surgical needs and procurement expectations. First, prioritize development programs that target clear clinical pain points-such as reducing tissue drag, improving knot security in ultrafine gauges, and delivering consistent handling across lots-and validate these advances through surgeon-led usability studies and documented bench performance assessments. Second, diversify sourcing footprints and establish alternate suppliers or nearshore manufacturing to mitigate tariff exposure and customs volatility while maintaining equivalency validation protocols for any material substitutions.

Third, tailor commercial engagement by offering flexible packaging and stocking options that suit the distinct needs of ambulatory surgery centers, eye clinics, and hospitals, and invest in clinician education programs that demonstrate technique-specific benefits. Fourth, enhance procurement confidence by strengthening quality system transparency, providing country-of-origin documentation, and including contractual protections that address trade policy fluctuations. Finally, integrate sustainability considerations where feasible-optimizing sterile packaging and waste reduction without compromising sterility-to meet growing institutional expectations and support long-term institutional partnerships.

These coordinated actions will help manufacturers and distributors safeguard clinical reliability while creating differentiation grounded in performance, service, and operational resilience.

Transparent description of primary and secondary research methods, data triangulation, and limitations informing the ophthalmic suture strategic analysis

This research synthesizes primary interviews with surgical practitioners, procurement leaders, and industry experts combined with secondary review of regulatory guidance, materials science literature, and publicly available clinical studies relevant to ophthalmic suture performance. Primary inputs included structured interviews and qualitative usability sessions with ophthalmic surgeons across subspecialties, procurement officers from ambulatory surgery centers and hospitals, and sterilization and quality assurance professionals who validate incoming product lots. Secondary sources encompassed peer-reviewed studies addressing polymer biocompatibility, knot mechanics, and suture handling, as well as regulatory documents outlining sterile medical device requirements across major jurisdictions.

The analysis applied cross-validation between clinician-reported preferences and bench testing evidence for attributes such as tissue drag, knot security, and tensile retention. Supply chain impact assessments incorporated trade policy changes, distributor network structures, and typical lead-time scenarios to evaluate potential procurement responses. Limitations include variability in local procurement practices and the evolving nature of trade policy, both of which were addressed through scenario-based sensitivity checks and corroborative expert input. Where appropriate, recommendations were stress-tested against alternate sourcing and regulatory scenarios to ensure practical applicability for decision-makers.

Concluding synthesis of clinical, commercial, and supply chain imperatives that decision-makers should integrate to secure consistent performance and procurement resilience

Ophthalmic sutures occupy a critical intersection of materials science, microsurgical technique, and healthcare procurement, requiring a nuanced approach that bridges clinical evidence with supply reliability. The most effective strategies emphasize demonstrable product performance-validated through surgeon-driven usability testing and objective bench metrics-alongside operational excellence in sterilization, documentation, and logistics. Regional and policy dynamics, including recent tariff adjustments, underscore the need for diversified sourcing and contractual protections to ensure continuity of supply for hospitals, ambulatory surgery centers, and eye clinics.

Looking forward, stakeholders that prioritize targeted polymer improvements, invest in training that aligns product characteristics with surgical technique, and maintain transparent quality documentation will be best positioned to meet the evolving demands of ophthalmic practice. By integrating these elements into coherent commercial and clinical strategies, manufacturers and distributors can deliver products that satisfy both the tactile expectations of surgeons and the operational requirements of institutional purchasers, ultimately supporting improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ophthalmic Sutures Market, by Product Type

  • 8.1. Absorbable
    • 8.1.1. Polydioxanone
    • 8.1.2. Polyglactin 910
    • 8.1.3. Polyglycolic Acid
  • 8.2. Non Absorbable
    • 8.2.1. Polyamide
    • 8.2.2. Polyester
    • 8.2.3. Silk

9. Ophthalmic Sutures Market, by Material

  • 9.1. Polyamide
  • 9.2. Polydioxanone
  • 9.3. Polyester
  • 9.4. Polyglactin 910
  • 9.5. Polyglycolic Acid
  • 9.6. Silk

10. Ophthalmic Sutures Market, by Suture Type

  • 10.1. Braided
  • 10.2. Monofilament

11. Ophthalmic Sutures Market, by Application

  • 11.1. Cataract
  • 11.2. Cornea
  • 11.3. Glaucoma
  • 11.4. Lens Repair

12. Ophthalmic Sutures Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Eye Clinics
  • 12.3. Hospitals

13. Ophthalmic Sutures Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ophthalmic Sutures Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ophthalmic Sutures Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Ophthalmic Sutures Market

17. China Ophthalmic Sutures Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Alcon Inc.
  • 18.6. Aurolab
  • 18.7. B. Braun Melsungen AG
  • 18.8. Demetech Corporation
  • 18.9. Ethicon, Inc.
  • 18.10. Johnson & Johnson Vision
  • 18.11. Lotus Surgicals Pvt. Ltd.
  • 18.12. Mani, Inc.
  • 18.13. Medical Micro Instruments, Inc.
  • 18.14. Medtronic plc
  • 18.15. Merit Medical Systems, Inc.
  • 18.16. Peters Surgical Limited
  • 18.17. Serag-Wiessner GmbH & Co. KG
  • 18.18. Surgical Specialties Corporation
  • 18.19. SUTUREMED Co., Ltd.
  • 18.20. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OPHTHALMIC SUTURES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL OPHTHALMIC SUTURES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES OPHTHALMIC SUTURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA OPHTHALMIC SUTURES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYAMIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLACTIN 910, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SILK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY BRAIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY BRAIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY BRAIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MONOFILAMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MONOFILAMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY MONOFILAMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CATARACT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CATARACT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CATARACT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CORNEA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CORNEA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY CORNEA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY LENS REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY LENS REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY LENS REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY EYE CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY EYE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY EYE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. GCC OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 155. GCC OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 156. GCC OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. GCC OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. GCC OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. G7 OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. G7 OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 179. G7 OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 180. G7 OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 181. G7 OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. G7 OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. G7 OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. NATO OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. NATO OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 187. NATO OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 188. NATO OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 189. NATO OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. NATO OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. NATO OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL OPHTHALMIC SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES OPHTHALMIC SUTURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA OPHTHALMIC SUTURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA OPHTHALMIC SUTURES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA OPHTHALMIC SUTURES MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA OPHTHALMIC SUTURES MARKET SIZE, BY NON ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA OPHTHALMIC SUTURES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA OPHTHALMIC SUTURES MARKET SIZE, BY SUTURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA OPHTHALMIC SUTURES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA OPHTHALMIC SUTURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)